Clinical trials have demonstrated that the expression of PD-L1 in ACC does not necessarily predict a positive clinical outcome; in fact, there are some patients with very impressive radiographic responses with ACC samples lacking PD-L1 expression [52,55]. Here, CD274 is linked to adrenal cortex carcinoma.